Upstream Bio, Inc.
UPB
$25.01
-$3.97-13.70%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 26.82% | 22.60% | -2.94% | -0.42% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 26.82% | 22.60% | -2.94% | -0.42% | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 26.82% | 22.60% | -2.94% | -0.42% | -- |
| SG&A Expenses | 63.44% | 74.98% | 66.12% | 60.52% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 110.80% | 112.50% | 96.90% | 88.58% | -- |
| Operating Income | -113.62% | -116.05% | -101.93% | -93.86% | -- |
| Income Before Tax | -128.90% | -157.91% | -176.57% | -205.82% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -128.90% | -157.91% | -176.57% | -205.82% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -128.90% | -157.91% | -176.57% | -205.82% | -- |
| EBIT | -113.62% | -116.05% | -101.93% | -93.86% | -- |
| EBITDA | -113.52% | -116.01% | -101.93% | -93.93% | -- |
| EPS Basic | 87.50% | 55.18% | 31.89% | -8.09% | -- |
| Normalized Basic EPS | 86.82% | 48.23% | -15.39% | -103.30% | -- |
| EPS Diluted | 87.50% | 55.18% | 31.89% | -8.09% | -- |
| Normalized Diluted EPS | 86.82% | 48.23% | -15.39% | -103.30% | -- |
| Average Basic Shares Outstanding | 1,623.98% | 1,207.07% | 797.72% | 374.24% | -- |
| Average Diluted Shares Outstanding | 1,623.98% | 1,207.07% | 797.72% | 374.24% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |